• Home
  • About
  • Portfolio
  • Meet the Team
  • News
  • Contact
  • Investor Portal

  • info@chv.vc

  • 129 South Street, 4th Floor, Boston, MA 02111

Home / News / AtaCor Medical

AtaCor Medical


AtaCor Medical Completes Enrollment in its Initial Acute Extravascular Implantable Cardioverter Defibrillator (EV-ICD) Study
  • December 20, 2021
  • -
  • AtaCor Medical
20 Medical Device Startups You Need to Know
  • June 26, 2020
  • -
  • AtaCor Medical
Atacor Raises $25M to Make Regulatory Case for Temporary Extracardiac Cardiac Pacing
  • April 29, 2020
  • -
  • AtaCor Medical
AtaCor Medical Secures $25M Financing to Continue Extracardiac Pacing Development
  • April 28, 2020
  • -
  • AtaCor Medical

Let’s Connect.

Contact Us
https://chv.vc/wp-content/uploads/2020/08/footer-logo.png

Sitemap

  • Home
  • About
  • Portfolio
  • Meet the Team
  • News
  • Contact
  • Investor Portal

About

Catalyst Health Ventures (CHV) is a venture capital fund investing in transformative medical technologies addressing global unmet needs.

Contact

  • info@chv.vc

Boston Web Design by GoingClear